Immunochemical Studies on Normal and Tay-Sachs'Brain Gangliosides
Pascal, T. A.; Saifer, A.; Gitlin, J.
Experimental Biology and Medicine 121(3): 739-743
1966
ISSN/ISBN: 1535-3702 DOI: 10.3181/00379727-121-30874
Accession: 061122875
PDF emailed within 0-6 h: $19.90
Related References
Pascal, T.A.; Saifer, A.; Gitlin, J. 1966: Immunochemical studies on normal and Tay-Sachs' brain gangliosides Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine 121(3): 739-743Klenk, E.; Kunau, W. 1965: On the incidence of Tay-Sachs gangliosides in normal human brain Acta Medica Academiae Scientiarum Hungaricae 21(4): 405-410
Svennerholm, L. 1962: The chemical structure of normal human brain and Tay-Sachs gangliosides Biochemical and Biophysical Research Communications 9: 436-441
Saifer, A.; Robin, M.; Volk, B.W. 1963: Chromatographic Studies of Normal and Tay-Sachs Gangliosides (Peptide-Strandin) Journal of Neurochemistry 10: 577-586
Halaris, A.; Jatzkewitz, H. 1969: Electron histochemical demonstration of gangliosides in normal and Tay-Sachs brain tissue Acta Neuropathologica 13(2): 157-168
Berman, E.R.; Gatt, S. 1961: Studies on gangliosides of Tay-Sachs brain BULL RES COUNC ISRAEL SECT A CHEM 10A(l): 28-29
Saifer, A. ,; Volk, B.W. 1963: Chromatographic Studies of Normal and Tay-Sachs Gangliosides (Peptide-Strandin) Journal of Neurochemistry 10(8): 577-586
Schneck, L.; Hoffman, L.M.; Brooks, S.E.; Amsterdam, D. 1980: Gangliosides containing glucosamine and galactosamine in transformed Tay-Sachs disease and normal human brain cell lines Journal of the Neurological Sciences 45(1): 123-128
Tallman, J.F.; Johnson, W.G.; Brady, R.O. 1972: The metabolism of Tay-Sachs ganglioside: catabolic studies with lysosomal enzymes from normal and Tay-Sachs brain tissue Journal of Clinical Investigation 51(9): 2339-2345
Gatt, S.; Berman, E.R. 1963: Studies on brain lipids in Tay-Sachs' disease. III. Solubility properties of gangliosides Journal of Neurochemistry 10: 65-72
Gatt, S.; Berman, E.R. 1963: Studies on brain lipids in Tay-Sachs' disease. II. Solubility properties of gangliosides Journal of Neurochemistry 10: 65-72
Gatt, S. 1965: Studies on Brain Tissue of Tay-Sachs Disease IV. Partitioning of Gangliosides into a Chloroform-Rich Phase Journal of Neurochemistry 12(4): 311-321
Gatt, S. 1965: Studies on Brain Tissue of Tay-Sachs' Disease. Iv. Partitioning of Gangliosides into a Chloroform-Rich Phase Journal of Neurochemistry 12: 311-321
Somers, J.E.; Kanfer, J.N.; Brady, R.O.; Boone, J.M. 1964: Immunochemical Studies with Gangliosides. Ii. Investigations of the Structure of Gangliosides by the Hapten-Inhibition Technique Biochemistry 3(2): 251-254
Wagner, A. 1966: Concerning brain gangliosides in Tay-Sachs disease Klinische Wochenschrift 44(7): 398-402
Stone, A.L.; Kolodny, E.H. 1971: Circular dichroism of gangliosides from normal and Tay-Sachs tissues Chemistry and Physics of Lipids 6(3): 274-279
Folch-Pi, J.; Lees, M. 1959: Studies on the brain ganglioside strandin in normal brain and in Tay-Sachs' disease A.M.A. Journal of Diseases of Children 97(5 Part 2): 730-738
Svennerholm, L. 1962: The chemical structure of human brain and Tay-Sachs gangliosides Biochem And Biophys Res Commun 9(5): 436-441
Klenk, E.; Liedtke, U.; Gielen, W. 1963: Brain Gangliosides in Infantile Amaurotic Idiocy of the Tay-Sachs type Hoppe-Seyler's Zeitschrift für Physiologische Chemie 334: 186-192
Hoffman, L.M.; Brooks, S.E.; Stein, M.R.; Adachi, M.; Schneck, L. 1989: Gangliosides in SV-40-transformed cells derived from Tay-Sachs disease fetal brain Metabolic Brain Disease 4(2): 87-93